ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,203Medicare Part D Prescriptions Filled, Including Refills

Rank: 167 out of 676

$591K Total Retail Price of All Prescriptions

Rank: 178 out of 676

365 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 365 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

17% of this provider’s 365 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 10,112 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
OMEPRAZOLE 461 373 1 2
FUROSEMIDE 380 314 2 4
AMLODIPINE BESYLATE 321 282 3 3
LISINOPRIL 307 242 4 5
WARFARIN SODIUM 284 258 5 18
GLIMEPIRIDE 268 248 6 30
HYDROCODONE-ACETAMINOPHEN 247 207 S3 7 1
DIOVAN 244 219 8 37
SIMVASTATIN 237 173 9 6
METOPROLOL SUCCINATE 218 193 10 14
DILTIAZEM ER 217 192 11 118
TRIAMTERENE-HCTZ 215 150 12 43
METFORMIN HCL 214 157 13 8
LEVOTHYROXINE SODIUM 209 171 14 7
CLOPIDOGREL 182 165 15 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 182 125 15 16
NEXIUM 180 160 17 23
POTASSIUM CHLORIDE 178 137 18 9
METOPROLOL TARTRATE 176 132 19 22
GABAPENTIN 164 133 20 10
DIOVAN HCT 159 111 21 41
NABUMETONE 151 115 22 179
PRAVASTATIN SODIUM 151 123 22 11
KLOR-CON M20 142 126 24 67
CYCLOBENZAPRINE HCL 140 76 R 25 50
FLUTICASONE PROPIONATE 134 119 26 49
SERTRALINE HCL 125 120 27 26
DONEPEZIL HCL 123 123 28 24
HYDROCHLOROTHIAZIDE 121 100 29 12
PLAVIX 121 114 29 40
CLONIDINE HCL 120 81 31 32
ATORVASTATIN CALCIUM 114 93 32 20
CARVEDILOL 114 100 32 15
ZETIA 109 86 34 89
NAMENDA 107 107 35 35
AZITHROMYCIN 95 78 36 39
TRIAMTERENE-HYDROCHLOROTHIAZID 94 85 37 160
ZOLPIDEM TARTRATE 90 90 38 21
CIPROFLOXACIN HCL 89 80 39 45
ATENOLOL 88 62 40 25
DIGOXIN 88 76 40 52
ALLOPURINOL 86 61 42 31
LANTUS 84 79 43 55
MECLIZINE HCL 73 66 44 83
FAMOTIDINE 71 57 45 64
PHENYTOIN SODIUM EXTENDED 71 53 45 88
HYDROXYZINE HCL 69 47 R 47 225
GLYBURIDE 68 68 R 48 92
MELOXICAM 67 49 49 13
COLCRYS 61 56 50 122
TERAZOSIN HCL 59 45 51 145
CEPHALEXIN 59 41 51 84
ISOSORBIDE MONONITRATE 59 47 51 394
NORTRIPTYLINE HCL 57 27 54 233
SYNTHROID 56 56 55 48
VERAPAMIL ER 54 47 56 101
BUMETANIDE 53 44 57 196
SPIRONOLACTONE 52 49 58 62
LANSOPRAZOLE 50 49 59 171
QUINAPRIL HCL 50 46 59 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.